|
|
The Effect of Macrophages on the Post-Implantation Reaction of Biomaterials and Tissue Regeneration |
Shi Jie, Tang Di Gao, Jingchen, Kong Deling, Wang Shufang* |
State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials for Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China |
|
|
Abstract There is a growing demand for biomaterials in clinical therapeutics. The implantation of biomaterials might end up in failure due to post-implantation inflammation. An effective approach to induce tissue regeneration would be the modulation of the macrophages responses to the implanted biomaterials. This review summaried the origin, subtypes, expression markers and functions of macrophages. Meanwhile strategies to induce macrophages toward the role of alleviating inflammation and promoting tissue regeneration after biomaterials implantation were introduced comprehensively. Some noteworthy challenges and directions in the research on facilitating tissue regeneration through the modulation of macrophages were discussed as well.
|
Received: 16 January 2017
|
|
|
|
|
[1] Galili U. Avoiding detrimental human immune response against Mammalian extracellular matrix implants [J]. Tissue Engineering Part B Reviews, 2015, 21(2):231-241. [2] Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs functional differentiation [J]. Frontiers in Immunology, 2014, 5(514):00514. [3] Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis [J]. Nature Reviews Immunology, 2014, 14(6):392-404. [4] Klopfleisch R. Macrophage reaction against biomaterials in the mouse model - phenotypes, functions and markers [J]. Acta Biomaterialia, 2016, 43:3-13. [5] Badylak SF, Valentin JE, Ravindra AK, et al.. Macrophage phenotype as a determinant of biologic scaffold remodeling [J]. Tissue Engineering Part A, 2008, 14(11):1835-1842. [6] Braga TT, Agudelo JS, Camara NO. Macrophages during the fibrotic process: M2 as friend and foe [J]. Frontiers in Immunology, 2015, 6(602): 0062. [7] Chavez-Galan L, Olleros ML, Vesin D, et al. Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages [J]. Frontiers in Immunology, 2015, 6(263):00263. [8] Gordon S, Taylor PR. Monocyte and macrophage heterogeneity [J]. Nature Reviews Immunology, 2005, 5(12):953-964. [9] Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment [J]. F1000Prime Reports, 2014, 6:13. [10] Roszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms [J]. Mediators of Inflammation, 2015, 2015:816460. [11] Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties [J]. Immunity, 2003,19(1):71-82. [12] Carlin LM, Stamatiades EG, Auffray C, et al. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal [J]. Cell, 2013, 153(2):362-375. [13] Crane MJ, Daley JM, van Houtte O, et al. The monocyte to macrophage transition in the murine sterile wound [J]. PLoS ONE, 2014, 9: e86660. [14] Gautier EL, Shay T, Miller J, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages [J]. Nature Immunology, 2012, 13(11):1118-1128. [15] Beljaars L, Schippers M, Reker-Smit C, et al. Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans [J]. Frontiers in Immunology, 2014, 5:430. [16] Wilson HM. SOCS Proteins in macrophage polarization and function [J]. Frontiers in Immunology, 2014, 5:357. [17] Porta C, Riboldi E, Ippolito A, et al. Molecular and epigenetic basis of macrophage polarized activation [J]. Seminars in Immunology, 2015,27(4):237-248. [18] Adhyatmika A, Putri KS, Beljaars L, et al. The elusive antifibrotic macrophage [J]. Frontiers in Medicine, 2015, 2:81. [19] Brodbeck WG, Anderson JM. Giant cell formation and function [J]. Current Opinion in Hematology, 2009, 16(1):53-57. [20] McNally AK, Anderson JM. Macrophage fusion and multinucleated giant cells of inflammation [J]. Advances in Experimental Medicine and Biology, 2011, 713:97-111. [21] Miron RJ, Bosshardt DD. OsteoMacs: Key players around bone biomaterials [J]. Biomaterials, 2016, 82:1-19. [22] Spiller KL, Anfang RR, Spiller KJ, et al. The role of macrophage phenotype in vascularization of tissue engineering scaffolds [J]. Biomaterials, 2014, 35(15):4477-4488. [23] Reinke JM, Sorg H. Wound repair and regeneration [J]. Eur Surg Res, 2012, 49(1):35-43. [24] Ogle ME, Segar CE, Sridhar S, et al. Monocytes and macrophages in tissue repair: implications for immunoregenerative biomaterial design [J]. Experimental Biology and Medicine, 2016, 241(10):1084-1097. [25] Veiseh O, Doloff JC, Ma M, et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates [J]. Nature Materials, 2015, 14(6):643-651. [26] Feng B, Jinkang Z, Zhen W, et al. The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo [J]. Biomedical Materials, 2011, 6(1):015007. [27] Garg K, Pullen NA, Oskeritzian CA, et al. Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds [J]. Biomaterials, 2013, 34(18):4439-4451. [28] Wang Z, Cui Y, Wang J, et al. The effect of thick fibers and large pores of electrospun poly(epsilon-caprolactone) vascular grafts on macrophage polarization and arterial regeneration [J]. Biomaterials, 2014,35(22):5700-5710. [29] Getts DR, Terry RL, Getts MT, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles [J]. Science Translational Medicine, 2014,6(219):219ra7. [30] Kennedy KM, Bhaw-Luximon A, Jhurry D. Cell-matrix mechanical interaction in electrospun polymeric scaffolds for tissue engineering: Implications for scaffold design and performance [J]. Acta Biomaterialia, 2017, 50:41-55. [31] Blakney AK, Swartzlander MD, Bryant SJ. The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels [J]. Journal of Biomedical Materials Research Part A, 2012, 100(6):1375-1386. [32] Patel NR, Bole M, Chen C, Hardin CC, et al. Cell elasticity determines macrophage function [J].PLoS ONE, 2012, 7(9):e41024. [33] Lee TT, Garcia JR, Paez JI, et al. Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials [J]. Nature Materials, 2015, 14(3):352-360. [34] Lutolf MP, Weber FE, Schmoekel HG, et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices[J]. Nature Biotechnology, 2003, 21(5):513-518. [35] Riabov V, Salazar F, Htwe SS, et al. Generation of anti-inflammatory macrophages for implants and regenerative medicine using self-standing release systems with a phenotype-fixing cytokine cocktail formulation [J]. Acta Biomaterialia, 1 Feb 2017, [Epub ahead of print]. [36] Vasconcelos DP, Costa M, Amaral IF, et al. Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators [J]. Biomaterials, 2015, 37:116-123. [37] Du F, Yu F, Wang Y, et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice [J]. Arteriosclerosis, Thrombosis, and Vascular biology, 2014, 34(4):759-767. [38] O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling [J]. Nature Reviews Immunology, 2011,11(3):163-175. [39] Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses [J]. Proceedings of the National Academy of Sciences of the United States of America, 2006,103(33):12481-12486. [40] Bazzoni F, Rossato M, Fabbri M, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals [J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(13):5282-5287. [41] Dong L, Wang C. Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering [J]. Trends in Biotechnology, 2013,31(6):342-346. [42] Roh JD, Sawh-Martinez R, Brennan MP, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling [J]. Proceedings of the National Academy of Sciences of the United States of America, 2010;107(10):4669-4674. [43] Zeng X, Zeng YS, Ma YH, et al. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury [J]. Cell Transplantation, 2011, 20(11-12):1881-1899. [44] Cho DI, Kim MR, Jeong HY, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages [J]. Experimental & Molecular Medicine,2014, 46:e70. [45] Adutler-Lieber S, Ben-Mordechai T, Naftali-Shani N, et al. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells [J]. Cardiovascular Pharmacology and Therapeutics, 2013, 18(1):78-86. [46] Freytes DO, Kang JW, Marcos-Campos I, et al. Macrophages modulate the viability and growth of human mesenchymal stem cells [J]. Cellular Biochemistry, 2013, 114(1):220-229. |
[1] |
Liao Shibo, Huang Shuyu, Xi Tingfei, Wu Min, Zou Yi, Li Ling, Zhu Zhao. Advances in Polymeric Biomaterial Scaffolds for Islet Transplantation[J]. Chinese Journal of Biomedical Engineering, 2017, 36(4): 490-496. |
[2] |
Hao Suisui Xu Haiyan# *. The Significance of Macrophage Phenotype in Injury as well as the Biomaterials Inducing Tissue Repair and Regeneration[J]. journal1, 2015, 34(4): 475-480. |
|
|
|
|